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The crisis of avoidable maternal, new-
born, and child deaths in developing
countries is currently a major focus for
the global health community (Box 1), and
it will be one of the leading issues
discussed at the September 2010 Summit
on the Millennium Development Goals
(MDGs) [1–3]. Many countries are off
track to reach the 2015 child and
maternal health MDGs (MDGs 4 and
5), and additional donor assistance will be
needed to help countries get back on
track.
How much donor assistance is currently
available for maternal, newborn, and child
health (MNCH) and how much additional
financing will be needed? In this article,
we examine the best estimates of current
donor assistance to MNCH and of future
funding that will be needed to reach
MDGs 4 and 5. We lay out several
limitations in these estimates. We end
with our recommendations for improving
the tracking of MNCH financing flows




The key source of data for estimating
official development assistance (ODA) to
MNCHistheCountdownto2015Initiative
(http://www.countdown2015mnch.org).
Countdown is a collaborative network of
organizations that monitors coverage
levels for interventions proven to reduce
maternal, newborn, and child mortality.
It published its first two reports in 2005 and
2008 (http://www.countdown2015mnch.
org/reports-publications), and two articles
in The Lancet in 2006 and 2008, that
include the MNCH financing estimates
(covering the years 2003–2006) [4,5].
Its third report, available at http://
www.countdown2015mnch.org/reports-
publications/2010-report, covers financing
flows up to 2007.
Which Donors Does Countdown
Assess?
Countdown examines ODA from 22
donor countries, members of the Develop-
ment Assistance Committee (DAC) within
the Organization for Economic Coopera-
tion and Development (OECD). DAC
describes itself as the ‘‘venue and voice of
the world’s major bilateral donors’’ [6].
DAC countries regularly report their assis-
tance to the OECD Creditor Reporting
System (CRS) database, an online database
of aid activities [7]. Countdown’s analysis
also includes contributions from the World
Bank, UNICEF, the GAVI Alliance,
the Global Fund, and the European
Commission.
A Rise in MNCH Financing
Countdown estimates that donor dis-
bursements for MNCH increased by 64%
between 2003 and 2006, from US$2.12
billion to $3.48 billion [4,5]. Countdown
separates child health financing from
maternal and neonatal health financing
(Box 2). Of the $3.48 billion disbursed in
2006, 66% ($2.31 billion) was spent on
child and 34% ($1.17 billion) on maternal
and neonatal health.
Where the Money Comes From
In 2006, 54% of donor assistance to
MNCH was from bilateral agencies, 31%
from multilateral financers (World Bank,
UNFPA, UNICEF, and the European
Commission), and 15% from the Global
Fund and GAVI Alliance. The two
leading MNCH financers were the World
Bank ($725m) and the US government
($692m). World Bank financing to
MNCH, however, may be overinflated
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the only organization that reported com-
mitments (not disbursements) to the CRS
database.
How Assistance Is Channeled
Nearly all donor support (95%) in 2006
went to funding specific health projects,
rather than providing health sector sup-
port (3%) or general budgetary support
(2%). Countdown differentiated between
three project types: (i) MNCH-specific
projects; (ii) projects that support general
health activities and contribute to MNCH
through health system improvement; and
(iii) disease-specific projects with benefit to
MNCH (e.g., an HIV/AIDS program that
assists the general population rather than
only mothers and children). In 2006,
about 51% ($1.67 billion) of project
funding went to MNCH-specific projects
(Box 3), while 29% went to general health
care projects ($0.95 billion) and 20% to
disease-specific projects ($0.65 billion).
Over the 2003–2006 time period,
several countries experienced sharp fluc-
tuations in aid inflows to MNCH, driven
by fluctuations in disbursements of large-
scale programs and initiatives (e.g., the
World Bank’s malaria booster project).
Countdown comments that this volatility
makes long-term planning difficult, espe-
cially for countries heavily dependent on
aid [5].
Was Funding Matched to Burden of
Disease?
Between 2003 and 2006, donor assis-
tance to MNCH was only partially based
on needs. While countries with higher
under-5 mortality received more assistance
per child, assistance to maternal and
newborn health was not well targeted
towards countries with the greatest needs.
Limitations in Estimating
Funding Flows to MNCH
There are several limitations in the
estimates of funding flows to MNCH in
Countdown’s first two studies [4,5]. These
limitations also apply to the estimates in
the June 2010 report—Countdown has
not been able to address these limitations
in its third report (Countdown member,
personal communication). Some, but not
all, of these limitations have been acknowl-
edged by Countdown [4].
CRS Database Lacks an MNCH
Category
When donors report to the CRS
database, they must choose a specific
‘‘purpose code’’ for their projects. CRS
has 17 purpose codes for health (e.g.,
malaria control) but no discrete category
for MNCH. This presented a challenge to
Countdown in trying to estimate how
much donors were spending on MNCH.
How did Countdown try to overcome
this problem? First, based on its own
classification of MNCH activities, Count-
down screened the CRS database for
MNCH financing. Projects were reviewed
based on the project title and descriptions,
and categorized accordingly. For projects
that specifically targeted the health of
mothers and/or children (‘‘MNCH-specif-
ic’’ projects), such as child immunization,
the entire disbursement was included in
the MNCH financing estimate. Using
project descriptions to estimate MNCH
funding has many pitfalls, as acknowl-
edged by Countdown itself: ‘‘these de-
scriptions can be vague, poorly translated
by the donor, or in languages that had to
be translated with online translation ser-
vices’’ [5].
Second, a proportion of the funding for
disease-specific projects and for integrated
funding (flowing through general health
care projects and budget support) was
included in the estimates of MNCH
funding. As these projects are usually
aimed at the general population, not just
mothers and children, the entire funding
cannot be included. Primary health care
projects, for example, are aimed at the
general population. Countdown therefore
created ‘‘allocation factors’’ [4] to calcu-
late the proportion of disease-specific and
integrated funding allocated to MNCH.
Box 4 gives a worked example of an
allocation factor.
Allocation Factors Are Based on
Weak Data
The quality of allocation factors relies
on the quality of the underlying country-
specific data, which are often poor. For
example, country-level data on the num-
ber of malaria cases in children under 5
years is not available for all Countdown
countries. So to indicate the proportion of
malaria project funds spent on child health
in a country, Countdown used region-specific
data as the basis for the allocation to child
health. Countdown argues that it has used
the best available data to create the
Summary Points
N Reliable estimates of current spending on maternal, newborn, and child health
(MNCH)—and of how much additional funding is needed—are a critical
precondition for sound policy and decision making.
N The Countdown to 2015 initiative estimates that, in 2006, donors spent US$3.48
billion on MNCH, of which 66% was spent on child health and 34% on maternal
and newborn health, but these estimates suffer from several limitations.
N Updated estimates for 2007, released by Countdown in June 2010 but not yet
available at the time of writing this article, have not addressed these limitations.
N The Consensus for Maternal, Newborn and Child Health argues that US$30
billion of additional funding is needed to save the lives of over 10 million
women and children by 2015.
N This US$30 billion ‘‘price tag’’ is misleadingly low because it leaves out crucial
service delivery costs.
N There is an urgent need to improve both the tracking of MNCH financing flows
and the estimation of additional MNCH resources required to reach the child
and maternal Millennium Development Goals.
Box 1. The Ongoing Crisis of Maternal, Neonatal, and Newborn
Deaths
Based on references [1–3]
Maternal mortality: Between 1990 and 2005, the global maternal mortality
ratio fell very little, from 430 to 400 per 100,000 live births.
Child mortality: The global under-5 mortality rate declined by 28% between
1990 and 2008. Substantial, but not sufficient, progress has been achieved toward
MDG 4.
Neonatal mortality: 41% of deaths among children under 5 years occur in the
first month of life.
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personal communication). However, many
of these proxies are based on outdated
data sources from studies done in the early
1990s (see web tables 2 and 3 in reference
[4]). To give just one example, to estimate
the proportion of total project funding for
hospital-level health care that was allocat-
ed to mothers, neonates, and children,
data from 1993 were used [4]. Countdown
acknowledges that ‘‘there is uncertainty
around the allocation factors and assump-
tions we use to apportion funds’’ [4].
Private and Nontraditional Donors
Are Not Included
Funding from foundations (e.g., the Bill
& Melinda Gates Foundation), nongov-
ernmental organizations (NGOs), and
nontraditional donors (e.g., China) are
not recorded in the CRS database and
are missing in the Countdown calcula-
tions. Yet they probably represent a
significant source of MNCH funding.
Similarly, the Countdown reports contain
no information on domestic MNCH
funding from low- and middle-income
countries. The 2010 Countdown report
continues to exclude these data.
Disbursements to Family Planning
Are Not Captured
Countdown’s financing estimates do not
include disbursements to family planning,
even though family planning is crucial to
improving women’s health. Countdown
plans to include family planning disburse-
ments for the 2012 report, though they are
still missing from the 2010 report.
Additional Financing Needs to
Reach MNCH Targets: What Is
the ‘‘Price Tag’’?
The US$30 Billion Price Tag
How much additional funding is needed
to reach MDGs 4 and 5? The ‘‘price tag’’
that has gained most traction in global
health circles is US$30 billion, an estimate
of the additional amount of funding
needed between 2009 and 2015 for
MNCH. The estimate comes from the
Consensus for Maternal, Newborn and
Child Health, a statement published by
the Partnership for Maternal, Newborn
and Child Health (PMNCH), a global
alliance of over 300 MNCH organizations
[8]. The estimate is based on calculations
included in a report by the High-Level
Taskforce on Innovative International
Financing for Health Systems (the HLTF)
[9]. The Taskforce established an inde-
pendent working group in 2008 to esti-
mate the costs of achieving the health-
related MDGs in 49 low-income countries,
with a special emphasis on MDGs 4 and 5.
The group established two different
technical teams, which developed two
separate cost estimates using different
methods. One team was led by WHO
(with UNAIDS and UNFPA), the other by
the World Bank (with UNICEF, PMNCH,
and UNFPA). Both teams calculated the
additional program costs for eight health
programs crucial to reaching the MDGs:
immunization, management of child ill-
nesses, maternal health, family planning,
TB, malaria, HIV/AIDS, and essential
drugs. Program costs included expendi-
tures for drugs, vaccines, and medical
supplies; infrastructure costs to overcome
program-specific barriers; and program
management costs. In addition to the
program costs, the teams estimated the
costs for providing crosscutting health
systems strengthening (HSS), including
the training and remuneration of health
workers and the building of new clinics.
What Does the US$30 Billion Pay
For?
The $30 billion figure in the MNCH
Consensus is based on WHO’s estimates of
the program costs alone between 2009 and
2015 required to scale up key MNCH
interventions related to just four of the eight
programs to universal coverage levels [9].
The US$30 billion provides an additional
US$11.82 billion for maternal health,
US$8.43 billion for family planning,
US$2.53 billion for the management of
childhood illnesses, and US$6.27 billion
for immunization, adding up to US$29.05
billion. The Consensus does not clarify
what the remaining US$0.95 billion would
cover.
Limitations in Estimating the
MNCH ‘‘Price Tag’’
The Price Tag Leaves Out HIV,
Malaria, TB, and Essential Drugs
The US$30 billion program costs do not
include the costs of HIV/AIDS, TB, and
malaria interventions relevant to MNCH
(e.g., drugs to treat children with malaria).
Nor do they include the costs to increase
access to essential drugs for treating
chronic and neglected tropical diseases.
Box 2. Expenditures on Child Health versus Maternal and
Neonatal Health
Based on references [4] and [5]
Child health expenditures: Spending on activities whose primary purpose is
to restore, improve, and maintain the health of children aged between 1 week
and 5 years, including: management of childhood illnesses (e.g., oral rehydration
therapy, zinc for diarrhea management, treatment of malaria, case management
of pneumonia); immunization; insecticide-treated nets; breastfeeding and
counseling; and micronutrient supplementation.
Maternal and neonatal health expenditures: Spending on activities whose
primary purpose is to restore, improve, and maintain the health of women and
their newborns during pregnancy, childbirth, and the early neonatal period,
including: antenatal, childbirth, and postnatal care; insecticide-treated nets for
pregnant women; anti-malarial intermittent preventive treatment; prevention of
vertical transmission of HIV; and preventive and treatment services for the
newborn.
Box 3. Breakdown of 2006 Donor Support for MNCH-Specific
Projects
Within the category of MNCH-specific projects, the breakdown of funding was as
follows:
N Immunization projects (28%)
N MNCH projects with an unspecified purpose, e.g., the project title simply
referred to ‘‘improving the health of mothers’’ (28%)
N Maternal health/safe motherhood (21%)
N Nutrition (13%)
N Child health (8%)
N Other projects (2%)
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tions for HIV/AIDS, TB, and malaria and
essential drugs specifically for mothers,
newborns, and children is unclear from
the HLTF report. The report only gives
the total figures for these four health
programs across the whole population:
US$15.13 billion is needed for HIV/
AIDS, US$7.25 billion for malaria,
US$4.78 billion for TB, and US$9.78
billion to increase access to essential drugs
[9,10]. A substantial proportion of these
costs will be relevant to MNCH.
The Price Tag Leaves Out HSS
A more serious omission is that the price
tag does not include HSS, i.e., the costs to
scale up the system-wide components,
including human resources, which would
allow programs to function effectively.
According to the WHO estimates for the
HLTF, US$185.7 billion is needed for
HSS [9,10]. Again, a substantial propor-
tion of this figure is highly relevant to
MDGs 4 and 5.
The Costing Estimate Is Misleading
The Consensus for Maternal, Newborn
and Child Health suggests that US$30
billion will save ‘‘the lives of over 10
million women and children by 2015’’ [8],
a suggestion that has gained traction
among donors and MNCH advocates.
But the US$30 billion alone is unlikely to
save over 10 million lives, since it must be
complemented by a huge amount of
additional funding for human resources
and other crosscutting health system
components.
A recent UNFPA study estimates that
meeting existing needs for family planning
and maternal and newborn health alone
would cost an additional US$12.8 billion
annually [11]. This estimate—which in-
cludes the costs of drugs and supplies,
human resource costs, and other health
systems costs needed for effective service
delivery—indicates that many more re-
sources are required for scaling up MNCH




The MNCH costing work is hampered
by disagreement about the best method-
ology used to estimate the financing needs.
For the report by the HLTF, WHO and
the World Bank came up with very
different figures for the MNCH price tag,
in part because they used different meth-
ods (Box 5). While the WHO figure on the
programmatic costs for MNCH was
US$30 billion, the World Bank figure
was considerably lower. The World Bank
estimate of the additional funding needs
for maternal health, family planning,
management of child diseases, and immu-
nization was just US$16.97 billion (though
it estimates that the cost for crosscutting
HSS is US$68.9 billion).
The estimates vary not only because of
the underlying methods but also because
of diverging views on how to best scale up
services to meet the MDGs. World Bank
estimates assume a delivery strategy that
emphasizes full scale up of community-
based services before expanding clinical
services. Major investments for the provi-
sion of clinical services are not introduced
until the final years of the period 2009–
2015. Its scale-up targets are less ambitious
than the WHO’s targets. The WHO costs
are based on a facility-based approach,
emphasizing the building of new health
centers and hospitals and the need for
more nurses and midwives. The WHO
approach takes a more optimistic view of
the speed with which new infrastructure
can be put into place.
Policy Recommendations
Below, we offer a set of policy recom-
mendations to overcome weaknesses in
tracking MNCH financing flows and in
estimating the MNCH ‘‘price tag.’’
Improved Reporting of MNCH
Financing Data
First, although the timeliness of donor
reporting has improved in recent years,
there is room for improvement. While
OECD donors were expected to report
their 2008 financing data to the DAC’s
Statistics and Monitoring Division by mid-
July 2009, only half of them complied with
this reporting deadline (DAC Secretariat,
personal communication). Many donor
governments provided the requested data
in October 2009, whereas one major
donor only made the data available in
December 2009 (i.e., five months late).
Large donors in particular, such as the
US and France, with large administrations
and many different agencies involved in
development finance, often do not report
data in a timely way to the CRS. As the
DAC only releases the complete yearly
data, such reporting behavior by donors
delays the timely release of the CRS data.
This delay makes it difficult to track if
donors are living up to their commitments
and contradicts the accountability princi-
ples of the Paris Declaration on Aid
Box 4. Using an Allocation Factor to Calculate Spending on
Childhood HIV/AIDS
To calculate the proportion of total HIV/AIDS funds spent on treatment of HIV-
positive children, Countdown started by looking at the total amount of donor
funding for HIV/AIDS in a particular country. It then used an allocation factor to
estimate how much of this total was spent on children. It used country-level
estimates of the proportion of the total population with HIV who were under 5
years of age (e.g., if 10% of people living with HIV/AIDS in a country were children
under 5 years, 10% of the HIV/AIDS funding would be included in the MNCH
financing estimates).
Box 5. Different Methods Used by the WHO and World Bank to
Estimate the MNCH ‘‘Price Tag’’
WHO approach: WHO uses a normative costing approach that estimates the
resources required to scale up country health systems to universal coverage
levels; i.e., it estimates the cost of meeting the health MDGs by using country-
specific intervention costs and then multiplying by the uncovered population.
The normative approach considers the amount of resources required to scale up
country health systems to a level that is considered ‘‘best practice’’ and responds
to the technical requirements for scaling up established by the various technical
programs [11].
World Bank approach: The World Bank’s marginal budgeting for bottlenecks
approach considerably differs from WHO’s costing approach. Building on health
data reported by developing countries, it identifies important health systems
constraints (bottlenecks) and then calculates the cost of strategies to remove
programmatic and health systems bottlenecks, and their returns in terms of
health outcomes. For the HLTF report, the World Bank team has calculated three
different scaling up scenarios, of which only one (medium) was included in the
report [19].
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Action [12]. Reporting delays are also a
stumbling block to answering other im-
portant questions in a timely manner, such
as how the global economic downturn
affects donor assistance to MNCH.
Second, donor countries should better
coordinate their MNCH reporting and
improve the quality of the reported
information. An initial step toward a
coordinated reporting format would be
for donors to agree upon specified key-
words that would be systematically includ-
ed in the CRS project descriptions. In the
context of a WHO request to better track
donor assistance to the health MDGs, in
2007 the DAC Secretariat recommended
that DAC members use the keyword
‘‘child health’’ (or its equivalent in French)
in the project descriptions. However, one
member objected to this proposal (DAC
Secretariat, personal communication).
Since a key challenge for Countdown is
the weak project descriptions in the CRS
database, a better use of the project
description field by the DAC members is
even more important than introducing
keywords. Precise, complete, and coherent
project descriptions would help to make
MNCH financing estimates more evi-
dence-based by showing how funds are
spent. This effort should be supported by
increased investments in the accounting
systems of donors, which are often not
designed to track actual MNCH-related
disbursements. The main reason why
donors are not willing to make better use
of the project description field in the CRS
database, to introduce keywords that can
be used to search for MNCH expendi-
tures, or to improve their accounting
systems is the increased reporting costs.
However, to achieve better estimates of
MNCH financing flows, donors need to
invest more in their reporting obligations
and accounting systems.
Better Allocation Factors
The crosscutting nature of MNCH
means that simply adding a category
called ‘‘MNCH’’ to the CRS database
would not be a solution. There will always
be to be a need to apportion a percentage
of disease-specific and integrated funding
to MNCH. Estimates of donor flows to
MNCH would be improved through the
creation of better allocation factors, which
means: (a) updating the data sources used
to calculate these factors, and (b) donors
investing in the necessary data collection,
monitoring, evaluation, and operational
research. In the short term, allocation
factors that are based on outdated sources
should be replaced by factors based on
updated data. Donors should fund new
studies that help to create better allocation
factors (e.g., better data are needed to help
estimate the proportion of total project
funding for hospital-level health care that
gets allocated to mothers, newborns, and
children).
Inclusion of Disbursements from
Nontraditional Donors
The contributions of key private finan-
cers, such as the Bill & Melinda Gates
Foundation, NGOs, and emerging donor
governments, can be mined from various
sources. We acknowledge that tracking
data that fall outside the CRS database
presents difficulties, including the increased
risk of ‘‘double counting’’ (e.g., Countdown
includes funding flows through the GAVI
Alliance, but GAVI is itself supported by
the Gates Foundation). Yet the Institute for
Health Metrics and Evaluation (http://
www.healthmetricsandevaluation.org/) has
managed to track ‘‘nontraditional’’ funding
flows to global health, including funding
from foundations and NGOs [13], as well
as domestic financing for health [14],
suggesting that difficulties in tracking non-
traditional funding can be overcome.
An Updated Price Tag before the
September 2010 MDG Summit
More accurate measures of the MNCH
price tag are needed—which include
health service delivery costs—so that
donor governments are given a realistic
picture of what it will take to cut maternal,
newborn, and child deaths. Accurate
estimates are needed to better inform the
discussions about MNCH financing at the
upcoming Summit on the MDGs in
September 2010.
While previous WHO estimates of
MNCH funding needs, from 2007, also
excluded crosscutting HSS costs, these
estimates did at least include important
service delivery costs, such as human
resource costs [15,16]. At a minimum,
this cost category should be included in the
MNCH price tag before the September
2010 MDG Summit.
Donors Should Support Countries in
Using the ‘‘One United Nations’’
Costing Method
Given the different costing methods
used by WHO and the World Bank to
estimate the MNCH ‘‘price tag’’ (Box 5),
we welcome the recent move to create a
‘‘one United Nations’’ costing method for
health [17]. An interagency working
group—UNAIDS, UNDP, UNFPA, UNI-
CEF, WHO, and the World Bank—is
currently harmonizing the various costing
tools used in the health sector [17]. The
aim is to develop a single UN tool, the
Unified Health Model, to support health
sector costing, budgeting, financing, and
strategy development in developing coun-
tries with a focus on medium-term MDG-
related health activities. Use of a ‘‘one
UN’’ costing tool should contribute to
better arguments for an increased com-
mitment to MNCH financing, both do-
mestically and globally, and developing
countries should be supported in using the
tool.
Conclusion
Important strategic decisions must be
made to accelerate progress toward
MDGs 4 and 5. Reliable estimates on
the currently available financial resources
and the funding gap are a critical
precondition for sound decision making
and for directing investments.
The current conversations in global
health circles about MDGs 4 and 5 refer
to the US$30 billion price tag for reaching
these goals. By promoting this figure,
which omits crucial service delivery costs,
we are concerned that the Consensus for
Maternal, Newborn and Child Health
risks raising false expectations about the
funding needed for impact.
There are two things we can say with
certainty. First, the current level of aid
devoted to MNCH is inadequate, provid-
ing only a fraction of the total resources
required to achieve the child and maternal
health MDGs. Second, donors are not
living up to their promises—in 2010,
Africa will receive only about US$12
billion of the $25 billion pledged by the
G8 at Gleneagles, due largely to the
underperformance of several European
donors [18]. Scaling up to reach MDGs
4 and 5 means urgently fixing these
shortfalls.
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